<DOC>
	<DOCNO>NCT01025544</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity booster dose two vaccine use prevent Haemophilus influenzae type b infection child 12-18 month age .</brief_summary>
	<brief_title>Study Toddlers ( 12-18 Months ) Comparing Booster Dose Vaxem Hib Hiberix Vaccines Prevention Haemophilus Influenzae Type b Infections China</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Toddlers 1218 month age previously participate study M37P2 . Prior Hib booster administration . History serious reaction ( ) follow vaccination . Vaccination within 14 day study vaccination . Known suspected immune impairment . For additional entry criterion please refer protocol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Haemophilus influenzae type b ( Hib )</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Booster</keyword>
</DOC>